- Home
- HUT vs WGS Comparison
HUT vs WGS Comparison
Compare HUT & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUT
- WGS
- Stock Information
- Founded
- HUT 2011
- WGS 2017
- Country
- HUT United States
- WGS United States
- Employees
- HUT N/A
- WGS N/A
- Industry
- HUT Finance: Consumer Services
- WGS Retail: Computer Software & Peripheral Equipment
- Sector
- HUT Finance
- WGS Technology
- Exchange
- HUT Nasdaq
- WGS Nasdaq
- Market Cap
- HUT 1.8B
- WGS 1.5B
- IPO Year
- HUT N/A
- WGS N/A
- Fundamental
- Price
- HUT $23.48
- WGS $72.07
- Analyst Decision
- HUT Strong Buy
- WGS Strong Buy
- Analyst Count
- HUT 5
- WGS 5
- Target Price
- HUT $32.60
- WGS $67.00
- AVG Volume (30 Days)
- HUT 8.1M
- WGS 803.4K
- Earning Date
- HUT 11-13-2024
- WGS 10-29-2024
- Dividend Yield
- HUT N/A
- WGS N/A
- EPS Growth
- HUT N/A
- WGS N/A
- EPS
- HUT 1.91
- WGS N/A
- Revenue
- HUT $194,021,000.00
- WGS $267,228,000.00
- Revenue This Year
- HUT $40.09
- WGS $43.70
- Revenue Next Year
- HUT $36.67
- WGS $16.78
- P/E Ratio
- HUT $12.27
- WGS N/A
- Revenue Growth
- HUT 209.07
- WGS 29.41
- 52 Week Low
- HUT $6.18
- WGS $1.41
- 52 Week High
- HUT $28.47
- WGS $89.11
- Technical
- Relative Strength Index (RSI)
- HUT 63.95
- WGS 55.01
- Support Level
- HUT $23.67
- WGS $66.00
- Resistance Level
- HUT $26.49
- WGS $75.21
- Average True Range (ATR)
- HUT 2.32
- WGS 6.23
- MACD
- HUT 0.20
- WGS -1.65
- Stochastic Oscillator
- HUT 62.57
- WGS 35.25
About HUT Hut 8 Corp.
Hut 8 Corp is engaged in the mining of digital assets with an operational focus on utilizing specialized equipment to solve complex computational problems to validate transactions on the Bitcoin blockchain and receiving Bitcoin in return for successful services. The company has four reportable business segments: Digital Assets Mining, Managed Services, High Performance Computing -Colocation and Cloud, and Other. It derives maximum revenue from Digital Assets Mining segment.
About WGS GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets. It has two segments GeneDx, which derives maximum revenue and Legacy Sema4 diagnostics.